Stage FocusSeed, Series A
GeographyUS, Global
TypeVC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
LongeVC is a longevity-focused biotech VC founded in 2020. Fund I raised $25M, backed 20 portfolio companies, achieved 3x+ MOIC, and placed in the top quartile — with zero write-offs. Fund II is now targeting $120M with a $2M minimum LP commitment.
The focus is regenerative medicine, AI-driven drug discovery, and age-related diseases spanning cancer, neurodegeneration, metabolic disorders, and ca...
Notable Investments
D
Deep LongevityR
Rubedo Life SciencesA
AOA DxSimilar Funds
Catalio Capital Management
New York, United States
DeepTech NativeBiotechMedTechSeedSeries A
Deerfield Management
New York, United States
DeepTech NativeBiotechMedTechSeedSeries A
Frazier Life Sciences
Palo Alto, United States
DeepTech NativeBiotechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A
4BIO Capital
Geneva, Switzerland
DeepTech NativeBiotechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A